
Loading, please wait...

Loading, please wait...

The National Medical Commission (NMC) has announced a crucial extension for the submission of the Annual Disclosure Report by existing medical colleges. This report is essential for the annual renewal of MBBS seats. It applies to the Academic Year (AY) 2026-27. The new NMC Annual Disclosure deadline is now June 10, 2026.
Previously, the deadline for submitting the Annual Disclosure Report was May 30, 2026. However, the Undergraduate Medical Education Board (UGMEB) of the NMC observed many medical colleges had not yet submitted their reports. Several factors contributed to this. These included reported technical issues and requests for additional time from various institutions. Consequently, the Competent Authority granted a final extension. This ensures all colleges have the opportunity to comply.
All medical colleges and institutions holding a valid Letter of Permission (LoP) for the MBBS course must submit their Annual Disclosure Report. This must be done on the official NMC portal. This requirement is mandated by Regulation 4 of the Maintenance of Standards of Medical Education Regulations, 2023 (MSMER, 2023). Institutions must ensure they are registered with AEBAS to access the portal. Importantly, the information provided must be accurate and consistent across all NMC Boards. Submitted data cannot be edited post-submission.
Furthermore, medical colleges need to pay a mandatory fee of Rs. 3,54,000, inclusive of 18% GST. This payment must be made online via the portal’s payment gateway. No other payment methods will be accepted. Colleges can access the submission portal at https://application.nmc.org.in/.
The NMC has clearly stated that the extension to June 10, 2026, is a "final opportunity". Therefore, no further extensions will be granted under any circumstances. Colleges experiencing technical difficulties or needing further information should contact the helpdesk. The email for support is ug.helpdesk@nmc.org.in. It is advised that all stakeholders treat this matter with urgency. This will help avoid any issues with the annual renewal of MBBS seats.
For more details on medical education standards, refer to the official National Medical Commission website www.nmc.org.in. Additionally, you may find relevant internal content on previous NMC updates helpful.
Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Important regulatory update! The National Medical Commission (NMC) has extended the Annual Disclosure Report deadline for MBBS seat renewal to June 10, 2026...
4 months ago

Following Nigeria's first recorded Ebola case linked to regional travel, the Africa CDC has convened an emergency ministerial summit. This alert underscores critical clinical priorities for healthcare professionals, including differentiating early viral infection from malaria, implementing barrier nursing, and triage.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today